Eccles SA - Search Results

1

Cytokine gene transfer as a therapeutic strategy.

Patel PM, Flemming CL, Russell SJ, Eccles SA, Collins MK. Patel PM, et al. Among authors: eccles sa. J Immunother Emphasis Tumor Immunol. 1993 Nov;14(4):310-3. doi: 10.1097/00002371-199311000-00010. J Immunother Emphasis Tumor Immunol. 1993. PMID: 8280713

2

Comparison of the potential therapeutic effects of interleukin 2 or interleukin 4 secretion by a single tumour.

Patel PM, Flemming CL, Russell SJ, McKay IA, MacLennan KA, Box GM, Eccles SA, Collins MK. Patel PM, et al. Among authors: eccles sa. Br J Cancer. 1993 Aug;68(2):295-302. doi: 10.1038/bjc.1993.331. Br J Cancer. 1993. PMID: 8347485 Free PMC article.

3

Prospects for tumour therapy using gene transfer.

Collins MK, Patel P, Flemming CL, Eccles SA. Collins MK, et al. Among authors: eccles sa. Bone Marrow Transplant. 1992;9 Suppl 1:171-3. Bone Marrow Transplant. 1992. PMID: 1504662 Review. No abstract available.

4

Decreased tumorigenicity of a transplantable rat sarcoma following transfer and expression of an IL-2 cDNA.

Russell SJ, Eccles SA, Flemming CL, Johnson CA, Collins MK. Russell SJ, et al. Among authors: eccles sa. Int J Cancer. 1991 Jan 21;47(2):244-51. doi: 10.1002/ijc.2910470213. Int J Cancer. 1991. PMID: 1988368

5

Monoclonal antibodies for the treatment of metastases. Evaluation of strategies using a syngeneic rat model.

Eccles SA, Box G, Court W, Collins MK, Dean CJ. Eccles SA, et al. Cell Biophys. 1993 Jan-Jun;22(1-3):165-87. doi: 10.1007/BF03033873. Cell Biophys. 1993. PMID: 7889538

6

Sarcoma cells engineered to secrete IFN-gamma or IL-2 acquire sensitization to immune cell killing via different mechanisms.

Flemming CL, Patel PM, Box G, Eccles SA, Collins MK. Flemming CL, et al. Among authors: eccles sa. Cytokine. 1997 May;9(5):328-32. doi: 10.1006/cyto.1996.0172. Cytokine. 1997. PMID: 9195131

7

Pharmacokinetic studies of radiolabelled rat monoclonal antibodies recognising syngeneic sarcoma antigens. I. Comparison of IgG subclasses.

Eccles SA, Purvies HP, Styles JM, Hobbs SM, Dean CJ. Eccles SA, et al. Cancer Immunol Immunother. 1989;30(1):5-12. doi: 10.1007/BF01665024. Cancer Immunol Immunother. 1989. PMID: 2598175 Free PMC article.

8

Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94).

Eccles SA, Box GM, Court WJ, Bone EA, Thomas W, Brown PD. Eccles SA, et al. Cancer Res. 1996 Jun 15;56(12):2815-22. Cancer Res. 1996. PMID: 8665519

9

Significance of the c-erbB family of receptor tyrosine kinases in metastatic cancer and their potential as targets for immunotherapy.

Eccles SA, Modjtahedi H, Box G, Court W, Sandle J, Dean CJ. Eccles SA, et al. Invasion Metastasis. 1994-1995;14(1-6):337-48. Invasion Metastasis. 1994. PMID: 7657527 Review.

10

Pharmacokinetic studies of radiolabelled rat monoclonal antibodies recognising syngeneic sarcoma antigens. II. Effect of host age and immune status.

Eccles SA, Purvies HP, Styles JM, Hobbs SM, Dean CJ. Eccles SA, et al. Cancer Immunol Immunother. 1989;30(1):13-20. doi: 10.1007/BF01665025. Cancer Immunol Immunother. 1989. PMID: 2598171 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters